SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT [Schedule] Condensed Statements of Cash Flows (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income (loss)	$ (30,395)	$ (5,335)	$ 10,909
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	6,406	6,438	6,251
Stock-based compensation	2,090	2,574	3,221
Other, net	562	481	131
Changes in assets and liabilities:
(Increase) decrease in prepaid and other assets	1,227	3,448	(202)
Increase (decrease) in accounts payable, accrued expenses and other liabilities	(2,100)	(22,452)	(2,534)
Increase (decrease) in accrued business reorganization expenses	818	1,878	(1,801)
Net cash provided by (used in) operating activities	2,513	13,159	13,396
Cash flows from investing activities:
Capital expenditures	(2,557)	(8,647)	(6,832)
Net cash provided by (used in) investing activities	(2,557)	(8,272)	(6,584)
Cash flows from financing activities:
Borrowings under credit agreements	17,314	74,534	237,779
Purchase of restricted stock from employees	(488)	(600)	(388)
Net cash provided by (used in) financing activities	(497)	(4,274)	1,639
Net (decrease) increase in cash and cash equivalents	(1,275)	1,351	7,779
Cash and cash equivalents, beginning of the period	38,653	37,302	29,523
Cash and cash equivalents, end of the period	37,378	38,653	37,302
Parent Company
Cash flows from operating activities:
Net income (loss)	(30,395)	(5,335)	10,909
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Dividends received from subsidiaries	2,341	6,255	4,515
Non-cash (income) losses from subsidiaries, net of taxes	22,522	1,103	(13,557)
Depreciation and amortization	645	641	595
Stock-based compensation	953	1,479	1,292
Other, net	368	368	365
Changes in assets and liabilities:
(Increase) decrease in prepaid and other assets	144	1,151	(987)
(Increase) decrease in due from subsidiaries	10,409	(6,736)	7,093
Increase (decrease) in accounts payable, accrued expenses and other liabilities	(1,597)	(2,443)	(828)
Increase (decrease) in accrued business reorganization expenses	134	40	0
Net cash provided by (used in) operating activities	5,524	(3,477)	9,397
Cash flows from investing activities:
Capital expenditures	(368)	(76)	(367)
Advances to and investments in subsidiaries, net	(6,673)	0	(1,438)
Net cash provided by (used in) investing activities	(7,041)	(76)	(1,805)
Cash flows from financing activities:
Borrowings under credit agreements	514	6,862	37,963
Repayments under credit facility	(514)	(6,862)	(37,963)
Purchase of restricted stock from employees	(488)	(600)	(388)
Net cash provided by (used in) financing activities	(488)	(600)	(388)
Net (decrease) increase in cash and cash equivalents	(2,005)	(4,153)	7,204
Cash and cash equivalents, beginning of the period	9,475	13,628	6,424
Cash and cash equivalents, end of the period	$ 7,470	$ 9,475	$ 13,628